Black Swift Group’s Zimmer Biomet ZBH Stock Holding History

Black Swift Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-75	Closed	-$12K	–	216
2021 Q1	$12K	Hold	75	–	–	﹤0.01%	158
2020 Q4	$11K	Buy	+75	New	+$10.6K	0.01%	128

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Black Swift Group's ZBH Position: Q2 2021 in Review

Black Swift Group sold out of Zimmer Biomet (ZBH) in Q2 2021, closing a stake of 75 shares — an estimated $12K sold.

Black Swift Group first reported a position in ZBH in Q4 2020 and held it in 2 quarters. The position peaked at $12K in Q1 2021. 1,018 funds tracked by Wall St. Rank hold ZBH as of Q2 2021.

Black Swift Group reported no remaining Zimmer Biomet position as of Q2 2021 after selling out during the quarter.
Black Swift Group sold 75 Zimmer Biomet shares in Q2 2021, an estimated $12K.
Black Swift Group first reported a position in Zimmer Biomet in Q4 2020 and held it in 2 quarters.
Black Swift Group's Zimmer Biomet position peaked at $12K in Q1 2021.
1,018 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2021.

Based on Black Swift Group's 13F filing for Q2 2021, filed 10 Aug 2021.